| Sep 5, 2014
| 5:17 PM
A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility to invent new drugs to combat diseases afflicting the elderly.
Half of the initial $500 million investment...
| Aug 31, 2014
| 6:34 PM
CytRx Corp. is on a mission to cure cancer — or at least slow it down.
The Los Angeles biopharmaceutical company, which recently has become embroiled in a stock-promotion controversy, specializes in researching and developing drugs to treat...
| Sep 2, 2014
| 9:37 PM
With the Ebola outbreak threatening to spiral out of control, U.S. officials unveiled a multimillion-dollar plan Tuesday aimed at getting a promising drug out of American research labs and into African hospitals and clinics more quickly.
| Sep 3, 2014
| 8:39 AM
Lake Forest-based drugmaker Hospira's talks to buy the medical nutrition unit of Danone and use the deal to move its tax domicile abroad have stalled, according to people familiar with the matter, as attempts by U.S. companies to relocate abroad and cut...
| Aug 26, 2014
| 3:45 PM
Allergan Inc. scheduled a Dec. 18 special meeting of its shareholders that could ultimately resolve a hostile takeover attempt by a Canadian rival.
Valeant Pharmaceuticals International Inc., which is based near Montreal, has been fighting since April...
| Aug 27, 2014
| 2:30 AM
Whether you get your prescription drugs through your employer's health plan or through a Medicare Part D plan, there are ways you can save on your medications.
Keep an eye out for new generic drugs. The patents for several popular brand-name drugs --...
| Aug 19, 2014
| 11:23 AM
With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
| Aug 21, 2014
Glades Drugs, a pharmacy retailer owned and operated by pharmacists, is opening new headquarters in Lake Worth.
The new 8,000-square-foot location at 4560 Lantana Road will feature office space, a lab and pharmacy. Glades Drugs, now based in Boca Raton,...
| Aug 21, 2014
| 12:11 PM
Baxter International Inc. said Thursday a key hemophilia drug under development met its primary goal in a late-stage clinical study.
The drug, known as BAX 855, is essentially a stronger, extended-release version of its flagship hemophilia drug Advate,...
| Aug 11, 2014
| 7:03 PM
A French pharmaceutical company has agreed to pay up to $925 million for the right to market Afrezza, the recently approved inhaled insulin treatment for diabetes developed by MannKind Corp. of Valencia.
Sanofi, based in Paris, said it would pay $150...
| Aug 12, 2014
| 2:18 PM
As U.S. medical experts raised concerns Tuesday about the use of experimental drugs to treat the Ebola virus, makers of the unapproved medication ZMapp said their supply has been "exhausted."
In a statement published online late Monday, Mapp...